A systematic review of the effectiveness of adalimumab
A systematic review of the effectiveness of adalimumab
A systematic review of the effectiveness of adalimumab
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
List <strong>of</strong> abbreviations continued<br />
MCP metacarpophalangeal joint<br />
MHAQ Modified Health Assessment<br />
Questionnaire<br />
MRI magnetic resonance imaging<br />
MTX methotrexate<br />
NA not applicable<br />
NICE National Institute for Health and<br />
Clinical Excellence<br />
NNH number needed to harm<br />
NNT number needed to treat<br />
NR not reported<br />
NSAID non-steroidal anti-inflammatory<br />
drug<br />
Pall palliation<br />
PCT primary care trust<br />
PREMIER A prospective, randomised trial<br />
(DE013) comparing <strong>adalimumab</strong>,<br />
methotrexate, and <strong>the</strong> combination<br />
<strong>of</strong> both over 2 years in patients<br />
with early rheumatoid arthritis<br />
PSS Personal and Social Services<br />
QoL quality <strong>of</strong> life<br />
QALY quality-adjusted life-year<br />
QSE quasi-standard error<br />
TNF-R tumour necrosis factor receptor<br />
RA rheumatoid arthritis<br />
RCT randomised controlled trial<br />
RD risk difference<br />
RR relative risk<br />
s.c. subcutaneous<br />
Health Technology Assessment 2006; Vol. 10: No. 42<br />
SAE serious adverse event<br />
SD standard deviation<br />
SDD smallest detectable difference<br />
SEER Surveillance Epidemiology and<br />
End Results<br />
SEM standard error <strong>of</strong> <strong>the</strong> mean<br />
SF-36 Short Form 36<br />
SJC swollen joint count<br />
SLE systemic lupus ery<strong>the</strong>matosus<br />
SMD standardised mean difference<br />
SSZ sulfasalazine<br />
STAR Safety Trial <strong>of</strong> Adalimumab in<br />
Rheumatoid Arthritis<br />
START Safety Trial for Rheumatoid<br />
Arthritis with Remicade Therapy<br />
sTNFR soluble tumour necrosis factor<br />
receptor<br />
TACE tumour necrosis factor-<br />
converting enzyme<br />
TEMPO Trial <strong>of</strong> Etanercept and<br />
Methotrexate with Radiographic<br />
Patient Outcomes<br />
TJC tender joint count<br />
TNF tumour necrosis factor<br />
TNF- tumour necrosis factor-<br />
VAS visual analogue scale<br />
WMD weighted mean difference<br />
WR weighted response<br />
All abbreviations that have been used in this report are listed here unless <strong>the</strong> abbreviation is well known (e.g. NHS), or<br />
it has been used only once, or it is a non-standard abbreviation used only in figures/tables/appendices in which case<br />
<strong>the</strong> abbreviation is defined in <strong>the</strong> figure legend or at <strong>the</strong> end <strong>of</strong> <strong>the</strong> table.<br />
© Queen’s Printer and Controller <strong>of</strong> HMSO 2006. All rights reserved.<br />
ix